Stock & Company Details
Fennec Pharmaceuticals Inc $FENC
Price:
N/A
N/A
35M
$475M
52 Week High:
N/A
10 Day Average Volume:
N/A
-115.35
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FENC technical indicators
Latest Fennec Pharmaceuticals Inc (FENC) indicator readings as of 2026-11-19.
FENC's 14-day RSI is 70.5, in overbought territory. ADX reads 25.7, indicating a trending market. MACD (12, 26, 9) is 0.66, above the zero line.
Overview
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Finance Bot
Ask your questions
Start by typing a question below.